TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Syngene International Ltd. ( (IN:SYNGENE) ) just unveiled an update.
Syngene International Ltd. has announced a scheduled meeting with Goldman Sachs on November 28, 2025, in Mumbai. This meeting is part of their ongoing engagement with analysts and institutional investors, and the company has assured that no unpublished price-sensitive information will be disclosed during the meeting.
More about Syngene International Ltd.
Syngene International Ltd. operates in the biotechnology industry, providing integrated research, development, and manufacturing services across various sectors, including pharmaceuticals, biotechnology, and agrochemicals. The company is based in Bengaluru, India, and focuses on delivering customized solutions to its global clientele.
Average Trading Volume: 64,839
Technical Sentiment Signal: Sell
Current Market Cap: 253.7B INR
For detailed information about SYNGENE stock, go to TipRanks’ Stock Analysis page.

